SCHWARZ PHARMA SAYS EU PANEL RECOMMENDS NEUPRO

A A

Schwarz Pharma AG, a German generic-drug maker moving into branded medicines, said a European Medicines Agency panel backed approval of its Neupro to treat patients with early stage Parkinson's disease. The company will start introducing the drug in the 25 European Union member states in the first half of 2006, pending full approval, Monheim-based Schwarz Pharma said. The shares rose as much as 6.9 percent.

Bloomberg (http://www.bloomberg.com/apps/news?pid=10000100&sid=aM_XBKaI5ipo&refer=germany)